Non-surgical management of pancreatic pseudocysts associated with arterial pseudoaneurysm

Pancreatology. 2013 May-Jun;13(3):250-3. doi: 10.1016/j.pan.2013.02.011. Epub 2013 Mar 14.

Abstract

Background: Pseudoaneurysms associated with pancreatic pseudocysts are different from simple, isolated pancreatic pseudoaneurysms and there is paucity of published data on their non surgical treatment.

Aim: To retrospectively analyze results of combination of angioembolisation or thrombin injection followed by endoscopic transpapillary drainage for management of pseudoaneurysms associated with pancreatic pseudocysts.

Methods: Eight patients (all males; mean age ± SD: 31.2 ± 6.1 years; age range: 21-38 years) underwent radiological management of the pseudoaneurysm followed by endoscopic drainage of the pseudocysts.

Results: All patients had pseudocysts (median size 4 cm) with underlying chronic pancreatitis. All patients had abdominal pain on presentation and 7/8 (87.5%) patients had presented with overt gastrointestinal bleeding. The size of the pseudoaneurysms varied from 1 to 4 cm. Two patients were treated with percutaneous thrombin injection whereas six patients underwent digital subtraction angiography and angioembolisation. All patients underwent successful endoscopic transpapillary drainage through the major (5) or minor papilla (3) and resolution of pseudocysts was noted within 6 weeks (median 4 weeks). No significant complication of the procedure was noted in any of the patients.

Conclusions: Pseudoaneurysms associated with pancreatic pseudocysts can be successfully and safely treated with a combination of radiological obliteration of the pseudoaneurysm followed by endoscopic transpapillary drainage.

MeSH terms

  • Administration, Cutaneous
  • Adult
  • Aneurysm, False / complications*
  • Aneurysm, False / therapy
  • Cholangiopancreatography, Endoscopic Retrograde
  • Drainage / methods
  • Endoscopy
  • Humans
  • Male
  • Pancreatic Pseudocyst / etiology
  • Pancreatic Pseudocyst / therapy*
  • Retrospective Studies
  • Thrombin / administration & dosage
  • Treatment Outcome

Substances

  • Thrombin